{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:07:05Z","timestamp":1777860425200,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.neurol.2017.06.021","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T04:43:17Z","timestamp":1520484197000},"page":"162-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Can anticoagulation therapy in cerebral venous thrombosis associated with Beh\u00e7et's disease be stopped without relapse?"],"prefix":"10.1016","volume":"174","author":[{"given":"M.","family":"Roriz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Crassard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lechtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Champion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Chabriat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"S\u00e8ne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2017.06.021_bib0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03009740500255761","article-title":"Characteristics of vascular involvememnt in Beh\u00e7et's disease","volume":"35","author":"D\u00fczg\u00fcn","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.neurol.2017.06.021_bib0065","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s00415-009-5088-4","article-title":"Cerebral venous thrombosis in Beh\u00e7et's disease compared to those associated with other etiologies","volume":"256","author":"Yesilot","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2017.06.021_bib0070","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","article-title":"Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT)","volume":"35","author":"Ferro","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2017.06.021_bib0075","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/art.24393","article-title":"Cerebral venous thrombosis in Beh\u00e7et's disease","volume":"61","author":"Saadoun","year":"2009","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.neurol.2017.06.021_bib0080","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The international criteria for Beh\u00e7et's disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. ITR-ICBD","volume":"28","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8697","key":"10.1016\/j.neurol.2017.06.021_bib0085","first-page":"1078","article-title":"International Study Group for Behcet's Disease","volume":"335","author":"Criteria for diagnosis of Behcet's Disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2017.06.021_bib0090","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","article-title":"Diagnosis and management of Neuro-Beh\u00e7et's disease: international consensus recommendations","volume":"261","author":"Kalra","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2017.06.021_bib0095","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/art.34450","article-title":"Immunosuppressants reduce venous thrombosis relapse in Beh\u00e7et's disease","volume":"64","author":"Desbois","year":"2012","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.neurol.2017.06.021_bib0100","doi-asserted-by":"crossref","first-page":"494e","DOI":"10.1097\/MD.0000000000000494","article-title":"Beh\u00e7et's disease with vascular involvement","volume":"94","author":"Alibaz-Oner","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.neurol.2017.06.021_bib0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10067-007-0685-z","article-title":"Treatment of venous thrombosis associated with Beh\u00e7et's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation","volume":"27","author":"Ahn","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.neurol.2017.06.021_bib0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9343(01)01048-8","article-title":"Vascular involvement in Beh\u00e7et's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin","volume":"112","author":"Espinosa","year":"2002","journal-title":"Am J Med"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716303563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716303563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T10:44:56Z","timestamp":1530528296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378716303563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0035378716303563"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2017.06.021","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can anticoagulation therapy in cerebral venous thrombosis associated with Beh\u00e7et's disease be stopped without relapse?","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2017.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}